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Abstract  
 
Conformational constrained β-hairpin peptides are useful tool to modulate protein-protein 
interactions. A triazole bridge in hydrogen bonded positions between two antiparallel strands 
induces a conformational stabilization of β-hairpin peptide. The entity of the stability of the β-hairpin 
peptide depends on the length of the bridge. 
  
Secondary structure elements present on protein surface are very often involved in protein-protein 
interactions governing biomolecules activity and function. Small peptides able to reproduce these 
secondary structure elements are useful tools to modulate protein-protein interaction with potential 
application, for example, in chemical biology and medicine. It is well known that amino acid 
segments excised from the protein environment seldom reproduce the native conformation as they 
are unfolded in solution.[1] In this context, the design of conformational constrained peptides, that 
mimic secondary structure motifs, is key to obtain bioactive molecules[2] or robust scaffolds onto 
graft the interacting residues keeping the correct spatial orientation.[3] 
The molecular factors governing β-hairpin folding and stability have been deeply studied and 
molecular tools to reproduce stable β-hairpin peptides have been reported.[4] Among the covalent 
tools to conformational stabilize a β-hairpin the closure of intramolecular triazole ring has been 
explored. A 1-4 disubstituted 1,2,3 triazole is obtained from side chains cyclization of alkyne and 
azide unnatural amino acids by means of Cu-catalyzed alkyne-azide cycloaddition (CuAAC),[5] 
forming a triazole ring linking the two antiparallel strands. This reaction is easy to perform, 
furnishing an enzymatic and chemical stable product in high yields, and does not need additional 
deprotection steps as the alkyne and azide functional groups are compatible with solid phase 
peptide synthesis protocol. In the last years, the CuAAC reaction gained much popularity and it has 
been widely employed for bioconjugation and biomolecules immobilization.[6] Recently, CuAAC has 
been also used to modify β-hairpin peptides. Holland-Nell and Meldal have demonstrated that the 
triazole can replace a disulfide bridge within β-hairpin structures,[7] Waters and co-workers reported 
a study on the conformational stability and function of the β-hairpin peptide modified by an 
interstrand triazole linkage,[8] and a triazolyl-bridged peptide mimicking the EGFR dimerization arm 
was developed, showing the inhibition of the allosteric activation of EGFR and an increased 
proteolytic stability.[9] 
Recently, we reported the use of interstrand 1-4 disubstituted 1,2,3 triazole as chemical tools to 
increase the conformational and proteolytic stability in β-hairpin peptide.[10] In particular, we 
analyzed the conformational stability of a series of β-hairpin peptides presenting the triazole 
bridge, with variable lengths, in a non-hydrogen bonded position and determined the structural 
requirements of the triazole bridge to achieve the greatest stabilization. The present study aims to 
evaluate the stabilizing effect of the triazole bridge in hydrogen-bonded (HB) positions of the β-
hairpin and the dependence, if any, on the length of the bridge. 
We analyzed a set of peptides which correspond to the previously described NHB peptides[10], 
based on Trpzip2 peptide[11], except for the position of the triazole bridge which was inserted in a 
hydrogen-bonded site (position 3 and 10) (Figure 1 and Figure S1). 
The peptides were referred to as HB x.y, where x and y represent the number of methylene groups 
on the side chain of the alkyne and azido amino acids; they also correspond to the methylene unit 
in position 4 and 1 of the triazole ring, respectively. The full peptide sequences are reported in 
table S1. HB peptides were synthesized by solid phase peptide synthesis using Fmoc chemistry. 
The purified linear peptides were cyclized through a Cu-catalyzed azide-alkyne cycloaddition 
reaction. HPLC and LC-MS analyses are reported in figure S2 and S3. 
The linear peptides and the corresponding cyclic peptides have the same molecular mass. As 
proof of intramolecular cyclization by CuAAC and the formation of 1,4 -disubstituted 1,2,3-triazole 
bridge we observed that: a) the HPLC retention times of cyclic peptides is shorter than the linear 
ones[12] (Table S2 and S3); b) the absence of odd multicharged peaks in the ESI-MS spectra 
characteristic of covalent dimer (Figure S3); c) cyclic peptides are stable to treatment with TCEP 
while linear peptide loss a mass of 26 Da as a consequence of the reduction of azide to amine[10,13] 
(see in Experimental section in supplementary information). 
To assess the conformational properties of HB peptides a conformational analysis in aqueous 
solution was performed by NMR spectroscopy. In particular, linear and cyclic peptides were 
analyzed by using a combination of 1D 1H, 2D [1H, 1H] TOCSY, 2D [1H, 1H] NOESY and 2D [1H, 
1H] COSY spectra. The 1D 1H NMR spectra of linear peptides display poor backbone amide 
protons (HN) chemical shift dispersion consistent with mostly unstructured conformations; instead, 
the 1H NMR spectra of cyclic peptides showed a good degree of dispersion, as occurs in a folded 
peptide (Figure 2 and Figure S4). The conformational state of linear and cyclic peptides was 
confirmed by the analysis of the splitting of the Gly7 diastereotopic Hα proton in the 2D TOCSY 
spectra. Particularly, linear peptides did not show the splitting of Gly7 Hα protons, confirming that 
linear peptides lack of turn structure, whereas cyclic peptides showed a significant Gly7 Hα 
splitting (Figure 3 and Table 1). 
The conformational properties of linear and cyclic peptides were determined qualitatively by 
comparing Hα chemical shifts relative to random coil values.[14] The plots of Hα chemical shift 
difference (ΔδHα) values for each cyclized peptide in aqueous solution at room temperature have 
the characteristic signature of a β-hairpin, indicating the presence of two β-strands (from residue 
Trp2 to Glu5 and from Thr9 to Val11) separated by a turn region centered on residues Asn6 and 
Gly7 (Figure 4). In contrast, the closeness of Hα chemical shifts to their random coil values (ΔδHα 
< 0.1 ppm) indicate that linear peptides in aqueous solution behave as mainly random coil 
conformation (Figure S5).  
Next, we investigated the influence of the number and position of substituent methylene units of 
the triazole ring on β-hairpin fold. The folded population content of each β-hairpin peptide was 
assessed with two methods. The first method estimates the extent of the diastereotopic Hα splitting 
of the turn residue Gly7 (ΔδGly).[15] The second method is based on the root mean square 
deviation (RMSD) values of Hα protons taken over all residues (RMSΔδHα).[16] These two methods 
examine different structural elements: the ΔδGly reflects the change in population of the turn 
residues, while RMSΔδHα values mainly reflect the contribution of residues in the β-strands. 
The folded populations were determined relative to the ΔδGly (0.50 ppm) and the RMSΔδHα 
values of trpzip2. The list of the observed Gly7 Hα splitting and RMSΔδHα values, together with 
the calculated fraction of folded population for all cyclic peptides are reported in table 1, figure 5 
and S6. The two methods resulted in good agreement; comparison of fraction-folded values 
derived from both Gly7 Hα splitting and the RMSΔδHα reveals that the cyclic peptides retain a 
folded β-hairpin in the range of 20−68% with respect to Trpzip2 population. The ΔδGly and the 
RMSΔδHα differ significantly for each cyclic peptide suggesting that β-hairpin content depends on 
the length of the triazole bridge with peptide HB3.3 showing the highest values between the HB 
peptide series (Figure 5).  
To gain a more detailed depiction of HB 3.3 folded structure, examination of long-range NOEs 
between residues in anti-parallel strands of the β-hairpin was carried out.  Several intense inter-
strand HN-HN and Hα-HN interactions (Table S4) are readily detected, constituting a strong evidence 
for HB 3.3 β-strand conformation.  
Overall, the formation of the triazole bridge in a hydrogen-bonded position induces a substantial 
conformational stabilization of a β-hairpin peptide with respect to the linear peptide. This result is 
interesting considering that a covalent tool, as disulfide bridge, failed to induce a conformational 
stabilization in β-hairpin peptides when inserted in a HB position.[17] The length of the bridge affects 
the peptide stability. In particular, a short bridge (HB 1.1, HB 2.1, HB 1.2) is weakly β-hairpin 
stabilizer, while the peptide folding content rise increasing the number of methylene units, being 
HB 3.3 the most folded peptide.  
Comparing the HB series with the previous reported NHB series[10] is evident that the triazole tool 
induces a similar energetic stabilization in both β-hairpin positions, being the β-hairpin content of 
the most folded peptide (HB 3.3 vs NHB 2.1) comparable in the two series (0.68 vs 0.60 
respectively). However, the highest stabilization is achieved with two different triazole bridges 
(HB3.3 vs NHB2.1). In particular, it seems that the most constrained position (HB) requires a more 
flexible bridge to achieve the maximal β-hairpin stabilization. 
In conclusion, the formation of a triazole bridge between two antiparallel strands induces a 
conformational stabilization of β-hairpin peptide when the tools is inserted in hydrogen bonded 
positions. The entity of β-hairpin stabilization depends on the length of the bridge, being maximum 
for longer bridge. This work completes our study on the determination of the optimal “triazole 
bridge” tool for the conformational stabilization of a β-hairpin peptide. 
  
Experimental Section 
Experimental details are reported as supplementary material. 
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Legends 
Figure 1. Generic molecular structure of HB peptides. The alkyne (Xaa) and azide (Yaa) amino 
acids are indicated in bold. Propargylglycine (Pra), homopropargylglycine (Hpg), 
bishomopropargylglycine (Bpg), L-β-azidoalanine (Dap(N3)), L-γ-azidohomoalanine (Dab (N3)), L-
δ-azidoornitine (Orn(N3)). 
Figure 2. 1H NMR spectra of A) HB 3.3 peptide and B) HB 3.3 linear peptide in aqueous solution. 
Spectra were recorded at 400 MHz and at 298 K. 
Figure 3. Section of the low field 2D [1H-1H]TOCSY spectra of cyclic and linear HB 3.3 peptides in 
water. Spectra were recorded at 400 MHz and 298 K. 
Figure 4. Bar plot of the deviation of  Hα chemical shift from random-coil values (ΔδHα) for Trpzip2 
and cyclized HB peptides. 
Figure 5. Fraction folded of peptides as determined by RMSΔδHα and ΔδGly Hα splitting values at 
298 K, using limiting shift values derived from trpzip2. 
  
TABLE 
Table 1. Fraction folded values for the HB clicked peptides 
Peptide ΔδGly Fraction folded[a] RMSΔδHα Fraction folded[b] 
HB 1.1 0.10 (±0.02) 0.20 (±0.02) 0.11 (±0.03) 0.25 (±0.03) 
HB 1.2 0.17 (±0.02) 0.34 (±0.01) 0.13 (±0.03) 0.30 (±0.01) 
HB 1.3 0.18 (±0.04) 0.36 (±0.02) 0.19 (±0.02) 0.43 (±0.03) 
HB 2.1 0.18 (±0.02) 0.36 (±0.03) 0.14 (±0.02) 0.32 (±0.02) 
HB 2.2 0.28 (±0.02) 0.56 (±0.02) 0.23 (±0.03) 0.52 (±0.02) 
HB 2.3 0.19 (±0.01) 0.38 (±0.02) 0.20 (±0.02) 0.45 (±0.02) 
HB 3.1 0.22 (±0.02) 0.44 (±0.01) 0.18 (±0.04) 0.41 (±0.02) 
HB 3.2 0.20 (±0.01) 0.40 (±0.01) 0.19 (±0.02) 0.43 (±0.02) 
HB 3.3 0.34 (±0.03) 0.68 (±0.03) 0.27 (±0.03) 0.61 (±0.03) 
[a] Fraction folded determined from ΔδGly Hα splitting values; [b] Fraction folded determined from the 
RMSΔδHα data. 
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Click chemistry to constrain β-hairpin peptides. Inserting the appropriate azide and alkyne component on a 
peptide chain can brings to the conformational stabilization of a β-hairpin peptide. 
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